Guardant Health Inc (GH)
18.26
+0.26
(+1.44%)
USD |
NASDAQ |
May 01, 16:00
18.31
+0.05
(+0.27%)
Pre-Market: 09:26
Guardant Health Debt to Equity Ratio: 7.184 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.184 |
| September 30, 2023 | 4.990 |
| June 30, 2023 | 3.890 |
| March 31, 2023 | -25.54 |
| December 31, 2022 | 18.90 |
| September 30, 2022 | 6.817 |
| June 30, 2022 | 3.560 |
| March 31, 2022 | 2.130 |
| December 31, 2021 | 1.759 |
| September 30, 2021 | 1.599 |
| June 30, 2021 | 1.438 |
| March 31, 2021 | 1.338 |
| December 31, 2020 | 0.6209 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | |
| December 31, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-25.54
Minimum
Mar 2023
18.90
Maximum
Dec 2022
1.510
Average
1.438
Median
Jun 2021
Debt to Equity Ratio Benchmarks
| Exact Sciences Corp | 0.7517 |
| Illumina Inc | 0.2592 |
| Delcath Systems Inc | 0.6433 |
| CytoSorbents Corp | 0.2167 |
| Progyny Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.786B |
| Total Liabilities (Quarterly) | 1.628B |
| Shareholders Equity (Quarterly) | 158.68M |
| Current Ratio | 6.542 |
| Net Debt Paydown Yield | -0.02% |